Lucila Garcia-Contreras to Drug Delivery Systems
This is a "connection" page, showing publications Lucila Garcia-Contreras has written about Drug Delivery Systems.
Connection Strength
1.427
-
Inhaled Formulation Design for the Treatment of Lung Infections. Curr Pharm Des. 2015; 21(27):3875-901.
Score: 0.409
-
In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev. 2007 Sep 30; 59(11):1133-51.
Score: 0.246
-
Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS PharmSci. 2003; 5(2):E9.
Score: 0.178
-
Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans. Crit Rev Ther Drug Carrier Syst. 2001; 18(4):387-431.
Score: 0.155
-
Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. J Pharm Sci. 2018 02; 107(2):638-646.
Score: 0.124
-
Mechanisms of absorption and elimination of drugs administered by inhalation. Ther Deliv. 2013 Aug; 4(8):1027-45.
Score: 0.093
-
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob Agents Chemother. 2007 Aug; 51(8):2830-6.
Score: 0.060
-
Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig. J Antimicrob Chemother. 2006 Nov; 58(5):980-6.
Score: 0.058
-
Aerosol treatment of cystic fibrosis. Crit Rev Ther Drug Carrier Syst. 2003; 20(5):317-56.
Score: 0.045
-
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs. 2018 08; 36(4):561-570.
Score: 0.031
-
Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology. J Pharm Sci. 1996 Feb; 85(2):144-9.
Score: 0.028